Hernexeos

Active Ingredient(s): Zongertinib
FDA Approved: * August 8, 2025
Pharm Company: * BOEHRINGER INGELHEIM
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Hernexeos 60 mg Oral Tablet, Film Coated
NDC: 0597-9257
Labeler:
Boehringer Ingelheim Pharmaceuticals, Inc.